Literature DB >> 23364232

Relationship between lung adenocarcinoma histological subtype and patient prognosis.

Halide Nur Urer1, Celalettin Ibrahim Kocaturk, Mehmet Zeki Gunluoglu, Naciye Arda, Mehmet Ali Bedirhan, Neslihan Fener, Seyyit Ibrahim Dincer.   

Abstract

PURPOSE: Lung adenocarcinoma (AC) demonstrates various histological subtypes within the tumour tissue. A panel established jointly by the IASLC, ATS and ERS classified invasive lung ACs based on the predominant histological subtype. We examined the distribution of tumours in lung AC patients according to histological subtype and analysed the effects of this classification on survival.
METHODS: The records of patients who had pulmonary resection for lung cancer between January 2000 and December 2009 were reviewed and 226 lung AC patients who fulfilled the inclusion criteria were identified. Histological subtypes of the ACs and their ratios in the tumour tissue were determined. Tumours were classified according to the predominant histological subtype and subsequently graded. The relationship between the predominant histological subtype, grade and survival were analysed.
RESULTS: Tumours were predominantly acinar in 99 cases (43.8%), solid in 89 (39.3%), lepidic in 20 (8.8%), and papillary in 11 (4.8%), whereas 7 tumours (3%) were variants of AC. Stage significantly affected survival (p = 0.001); however, the predominant histological subtype had no significant effect. The 5-year survival rate for patients with histologically grade II tumours was 48.6%, whereas that in patients with grade III tumours was 56%. (p = 0.69).
CONCLUSION: Invasive lung ACs may be defined by their predominant histological subtype. However, it is not yet possible to conclude that this classification is related to survival.

Entities:  

Mesh:

Year:  2013        PMID: 23364232     DOI: 10.5761/atcs.oa.12.02073

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  10 in total

1.  Reevaluation of survival and prognostic factors in pathologic stage I lung adenocarcinoma by the new 2009 TNM classification.

Authors:  Xiaohong Fan; Xueyan Zhang; Huimin Wang; Bo Jin
Journal:  Tumour Biol       Date:  2014-06

2.  The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know.

Authors:  Takashi Eguchi; Kyuichi Kadota; Bernard J Park; William D Travis; David R Jones; Prasad S Adusumilli
Journal:  Semin Thorac Cardiovasc Surg       Date:  2014-09-16

3.  Clinical significance of tumor necrosis and viability in non-small cell lung cancer.

Authors:  Seok Whan Moon; Jae Jun Kim; Seong Cheol Jeong; Yong Hwan Kim; Jung Wook Han
Journal:  J Thorac Dis       Date:  2022-04       Impact factor: 3.005

4.  Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease.

Authors:  Kyuichi Kadota; Jonathan Villena-Vargas; Akihiko Yoshizawa; Noriko Motoi; Camelia S Sima; Gregory J Riely; Valerie W Rusch; Prasad S Adusumilli; William D Travis
Journal:  Am J Surg Pathol       Date:  2014-04       Impact factor: 6.394

5.  Looking for Lepidic Component inside Invasive Adenocarcinomas Appearing as CT Solid Solitary Pulmonary Nodules (SPNs): CT Morpho-Densitometric Features and 18-FDG PET Findings.

Authors:  Alfonso Reginelli; Raffaella Capasso; Mario Petrillo; Claudia Rossi; Pierluigi Faella; Roberta Grassi; Maria Paola Belfiore; Giovanni Rossi; Maurizio Muto; Pietro Muto; Alfonso Fiorello; Nicola Serra; Rita Nizzoli; Massimo De Filippo; Salvatore Cappabianca; Gianpaolo Carrafiello; Luca Brunese; Antonio Rotondo
Journal:  Biomed Res Int       Date:  2019-01-13       Impact factor: 3.411

6.  Prognostic factors for stage I lung adenocarcinoma and surgical management of subsolid nodules.

Authors:  Gökhan Kocaman; Mustafa Bülent Yenigün; Atilla Halil Elhan; Serpil Dizbay Sak; Elvin Hamzayev; Serkan Enön; Ayten Kayı Cangır; Cabir Yüksel
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-09-16       Impact factor: 0.332

7.  MicroRNA Expression Profile on Solid Subtype of Invasive Lung Adenocarcinoma Reveals a Panel of Four miRNAs to Be Associated with Poor Prognosis in Chinese Patients.

Authors:  Yong-Qiang Zhang; Wei-Ya Wang; Jian-Xin Xue; Yan Xu; Ping Fan; Bennett Adam Caughey; Wei-Wei Tan; Gui-Qun Cao; Li-Li Jiang; You Lu; Kang Zhang; Xun Hu
Journal:  J Cancer       Date:  2016-07-18       Impact factor: 4.207

8.  Clinical Significance of Complex Glandular Patterns in Lung Adenocarcinoma: Clinicopathologic and Molecular Study in a Large Series of Cases.

Authors:  Muyu Kuang; Xuxia Shen; Chongze Yuan; Haichuan Hu; Yang Zhang; Yunjian Pan; Chao Cheng; Difan Zheng; Lei Cheng; Yue Zhao; Xiaoting Tao; Yuan Li; Haiquan Chen; Yihua Sun
Journal:  Am J Clin Pathol       Date:  2018-05-31       Impact factor: 2.493

9.  Gender Differences in the Recurrence Timing of Patients Undergoing Resection for Non-Small Cell Lung Cancer

Authors:  Katsuya Watanabe; Kentaro Sakamaki; Teppei Nishii; Taketsugu Yamamoto; Takamitsu Maehara; Haruhiko Nakayama; Munetaka Masuda
Journal:  Asian Pac J Cancer Prev       Date:  2018-03-27

10.  Prognostic Effects of Predominant Histologic Subtypes in Resected Pulmonary Adenocarcinomas

Authors:  Demet Yaldız; Şeyda Örs Kaya; Kenan Can Ceylan; Arkın Acar; Zekiye Aydoğdu; Soner Gürsoy; Sadık Yaldız
Journal:  Balkan Med J       Date:  2019-09-17       Impact factor: 2.021

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.